乳腺癌中医证候分类与预后相关性的初步研究  

A preliminary study on correlation between syndrome classification and prognosis of breast cancer

作　　者：安传国[1] 张玲 

机构地区：[1]日照市人民医院,山东日照276800 [2]日照市东港区河山卫生院,山东日照276800

出　　处：《中医临床研究》2017年第9期119-120,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:探讨乳腺癌中医证候分类与预后相关性。方法:选取2015年2月-2016年1月于我院就医的乳腺癌患者72例,所有患者均通过中医辨证进行分类,然后进行手术切除,并且在术后运用中医扶正解毒散结汤进行治疗,对比各类型患者的比例情况及各分期人数,总结中医治疗效果。结果:根据本次研究结果显示,在中医证候分类方面,实热证组人数占比最大;且与气虚、湿热证、血瘀证等其他组人数比例对比存在显著差异(P<0.05);而在肿瘤分期方面,II期患者人数占比最大,且与I期、Ⅲ期、IV期对比存在显著差异(P<0.05),乳腺癌患者术后选择中医扶正解毒散结汤整体治疗总有效率为94.44%。结论:乳腺癌中医证候分类主要是实热证,肿瘤分期II期居多,治疗应当遵循以上基础进行治疗。Objective:To explore TCM syndrome classification and prognosis of breast cancer.Methods:72breast cancer patients,all patients were classified by TCM syndrome differentiation,and then the surgical removal,and the postoperative appliaction of TCM Fuzheng Jiedu decoction.Results:According to the results of this study,the proportion of heat syndrome group was the largest in TCM syndromes classification,and there was significant difference(P<0.05);compared with other groups such as qi deficiency,damp-heat syndrome and blood syndrome,(P<0.05).The overall response rate of patients with breast cancer treated by Fuzheng Jiedu Sanjie decoction was significantly higher than that of stage I,III and IV(P<0.05).Conclusion:TCM syndrome classification of breast cancer mainly solid heat syndromes,mostly in the tumor stage II.

关 键 词：乳腺癌中医证候分类 预后相关性 研究分析 

分 类 号：R273[医药卫生—中西医结合]